title: Carboplatin: current status and future prospects.
authors.affiliation: Bristol-Myers Company, Pharmaceutical Research and Development, Wallingford, CT 06492-7600.
authors.forename: R
authors.initials: R
authors.lastname: Canetta
authors.forename: K
authors.initials: K
authors.lastname: Bragman
authors.forename: L
authors.initials: L
authors.lastname: Smaldone
authors.forename: M
authors.initials: M
authors.lastname: Rozencweig
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D014565:Urogenital Neoplasms / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D016190:Carboplatin